{"id":743,"date":"2023-06-28T06:37:43","date_gmt":"2023-06-28T06:37:43","guid":{"rendered":"https:\/\/eastmedia.lt\/owlet-paskelbia-atvirkstini-akciju-padalijima-dienomis-po-to-kai-fda-patvirtino-kudikiu-kojines\/"},"modified":"2023-06-28T06:37:43","modified_gmt":"2023-06-28T06:37:43","slug":"owlet-paskelbia-atvirkstini-akciju-padalijima-dienomis-po-to-kai-fda-patvirtino-kudikiu-kojines","status":"publish","type":"post","link":"https:\/\/easa.lt\/index.php\/2023\/06\/28\/owlet-paskelbia-atvirkstini-akciju-padalijima-dienomis-po-to-kai-fda-patvirtino-kudikiu-kojines\/","title":{"rendered":"\u201eOwlet\u201c paskelbia atvirk\u0161tin\u012f akcij\u0173 padalijim\u0105 dienomis po to, kai FDA patvirtino k\u016bdiki\u0173 kojines"},"content":{"rendered":"

<\/p>\n

\n

Pel\u0117da<\/span>technologij\u0173 \u012fmon\u0117, orientuojanti \u012f i\u0161man\u0173j\u012f k\u016bdiki\u0173 steb\u0117jim\u0105, paskelb\u0117, kad nuo liepos 7 d. prad\u0117s A klas\u0117s paprast\u0173j\u0173 akcij\u0173 atvirk\u0161tin\u012f padalijim\u0105 1 u\u017e 14.<\/p>\n

Prane\u0161imas paskelbtas pra\u0117jus vos savaitei po to, kai bendrov\u0117 prane\u0161\u0117, kad gavo FDA leidim\u0105 receptui <\/span>pulso oksimetrijos kojin\u0117s k\u016bdikiams, pavadintos BabySat. <\/p>\n

Kai Niujorko vertybini\u0173 popieri\u0173 bir\u017ea (NYSE) atsidarys liepos 10 d., akcijomis bus prekiaujama pagal padalijim\u0105, o akcij\u0173 nominali vert\u0117 pakeista \u012f 0,0001 USD u\u017e akcij\u0105.<\/span><\/p>\n

Bendrov\u0117 tikisi, kad padalijimas leis jai v\u0117l laikytis minimalios 1,00 USD vidutin\u0117s u\u017edarymo kainos, kurios reikalaujama akcijoms, kuriomis prekiaujama NYSE. <\/span><\/p>\n

Bendrov\u0117s prekybos simbolis OWLT d\u0117l padalijimo nebus pakeistas.<\/span><\/p>\n

\u201eNors \u0161\u012f atvirk\u0161tin\u012f akcij\u0173 padalijim\u0105 pirmiausia lemia techninis atitikimas NYSE minimalios akcij\u0173 kainos reikalavimui, verslo esm\u0117 ir toliau ger\u0117ja\u201c, \u2013 prane\u0161ime teig\u0117 Kurtas Workmanas, \u201eOwlet\u201c generalinis direktorius ir vienas i\u0161 \u012fk\u016br\u0117j\u0173. „Esame optimisti\u0161kai nusiteik\u0119 d\u0117l pa\u017eangos, kuri\u0105 darome gerindami mar\u017e\u0105, kanal\u0173 b\u016bkl\u0119 ir siekdami pelningumo. Pra\u0117jusi\u0105 savait\u0119 paskelbus pirm\u0105j\u012f FDA leidim\u0105, d\u017eiaugiam\u0117s \u0161ios kategorijos ateitimi ir i\u0161pl\u0117stine prieiga ir pri\u0117mimu, kur\u012f patvirtina reguliavimo institucijos. duos t\u0117vams visame pasaulyje\u201c.<\/span><\/p>\n

DIDESN\u0116 TENDENCIJA<\/span><\/strong><\/p>\n

2021 m. <\/span>bendrov\u0117 i\u0161leido \u012f bir\u017e\u0105 per SPAC, NYSE prekiaujant vos ma\u017eiau nei 10 USD u\u017e akcij\u0105 atidarius. \u0160iuo metu jos kaina yra apie 0,35 USD u\u017e akcij\u0105. <\/p>\n

Savo <\/span>Naujausioje 2023 m. pirmojo ketvir\u010dio pajam\u0173 ataskaitoje k\u016bdiki\u0173 technologij\u0173 \u012fmon\u0117 prane\u0161\u0117 apie 10,7 mln. USD pajamas, palyginti su 21,5 mln. USD 2022 m. pirm\u0105j\u012f ketvirt\u012f. <\/p>\n

Pirm\u0105j\u012f \u0161i\u0173 met\u0173 ketvirt\u012f veiklos nuostolis buvo 11 mln. USD, palyginti su 21,7 mln. USD 2022 m. pirm\u0105j\u012f ketvirt\u012f, o grynasis nuostolis sudar\u0117 11,9 mln. USD, palyginti su 28,8 mln. <\/span><\/p>\n

2023 m. pirm\u0105j\u012f ketvirt\u012f pakoreguotas EBITDA nuostolis buvo apie 5,8 mln. USD, palyginti su 18 mln. USD pra\u0117jusi\u0173 met\u0173 pirm\u0105j\u012f ketvirt\u012f. <\/span><\/p>\n

Vasario m\u0117nes\u012f bendrov\u0117 paskelb\u0117, kad padidino <\/span>30 milijon\u0173 JAV doleri\u0173 privataus investavimo finansavimui. <\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Pel\u0117datechnologij\u0173 \u012fmon\u0117, orientuojanti \u012f i\u0161man\u0173j\u012f k\u016bdiki\u0173 steb\u0117jim\u0105, paskelb\u0117, kad nuo liepos 7 d. prad\u0117s A klas\u0117s paprast\u0173j\u0173 akcij\u0173 atvirk\u0161tin\u012f padalijim\u0105 1 u\u017e 14. Prane\u0161imas paskelbtas pra\u0117jus vos savaitei po to, kai bendrov\u0117 prane\u0161\u0117, kad gavo FDA leidim\u0105 receptui pulso oksimetrijos kojin\u0117s k\u016bdikiams, pavadintos BabySat. Kai Niujorko vertybini\u0173 popieri\u0173 bir\u017ea (NYSE) atsidarys liepos 10 d., akcijomis […]<\/p>\n","protected":false},"author":2,"featured_media":744,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-743","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bendri"],"_links":{"self":[{"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/posts\/743","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/comments?post=743"}],"version-history":[{"count":0,"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/posts\/743\/revisions"}],"wp:attachment":[{"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/media?parent=743"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/categories?post=743"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/tags?post=743"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}